CD4 and Hepatic fibrosis: Nadir CD4+ T cell percentage <10% was more common in progressors compared to non-progressors, (when liver fibrosis was defined either by 9/11 (82%) versus 15/44 (34%) stage [Table 2], or 8/9 (89%) versus 16/46 (35%) by kPa [Supplementary Table S8]).